Compare PTCT & LSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | LSTR |
|---|---|---|
| Founded | 1998 | 1988 |
| Country | United States | United States |
| Employees | 991 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.9B |
| IPO Year | 2006 | 1994 |
| Metric | PTCT | LSTR |
|---|---|---|
| Price | $63.29 | $162.87 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 12 |
| Target Price | $80.65 | ★ $173.83 |
| AVG Volume (30 Days) | ★ 918.2K | 260.5K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.95% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | 0.90 | ★ 1.16 |
| Revenue | $264,734,000.00 | ★ $4,743,760,000.00 |
| Revenue This Year | N/A | $6.89 |
| Revenue Next Year | $17.70 | $9.05 |
| P/E Ratio | ★ $69.20 | $142.40 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $58.90 | $120.01 |
| 52 Week High | $90.87 | $228.46 |
| Indicator | PTCT | LSTR |
|---|---|---|
| Relative Strength Index (RSI) | 34.72 | 29.07 |
| Support Level | N/A | $142.52 |
| Resistance Level | $68.93 | $165.68 |
| Average True Range (ATR) | 1.97 | 4.01 |
| MACD | -0.32 | -0.36 |
| Stochastic Oscillator | 22.43 | 8.09 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.